Pairings | GenomeWeb

Pairings

Premium

Bernd Brust will transition out of his position as president of Life Technologies' commercial operations and will take on the role of president of molecular medicine at the company, according to a filing yesterday with the US Securities and Exchange Commission.

Brust will be replaced as president of commercial operations at the start of 2011 by Nicolas Barthelemy, who has been leading Life Technologies' cell systems division.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.